Highlights
- Wockhardt shares declined over 7% after a sharp rally to multi-year highs.
- The stock remains well above its 21-day SMA despite the recent correction.
- RSI continues to stay above 70, indicating elevated momentum conditions.
Overview
Wockhardt (NSE: WOCKPHARMA) came under selling pressure on June 2, with shares falling 7.03% to INR 2,001.60 after an exceptional rally over recent weeks. The stock had surged to fresh highs above INR 2,100 before profit booking emerged. Despite the decline, Wockhardt continues to trade significantly above key technical averages, suggesting that the broader uptrend remains intact for now.
Fundamental View
For the quarter ended March 2026, Wockhardt reported standalone total income of INR 57,100.00 lakh. Profit before tax stood at INR 16,700.00 lakh, while net profit also came in at INR 16,700.00 lakh. Earnings per share (EPS) was reported at INR 10.29.
The latest quarterly performance reflected healthy profitability and earnings generation. Strong financial results have contributed to the significant re-rating witnessed in the stock over recent months.
Technical View
Wockhardt traded at INR 2,001.60, down 7.03% during the session. Despite the correction, the stock remains comfortably above its 21-day SMA of INR 1,669.17, indicating that the broader technical structure continues to remain positive.
Recent price action suggests profit booking following a steep rally rather than a confirmed trend reversal. The stock had become extended after a rapid advance above the INR 2,000 mark, leading to a pullback as traders locked in gains.
The 14-day RSI stood at 70.70, remaining above the overbought threshold. While momentum has eased from recent peaks, it continues to indicate a strong underlying trend.
Momentum Indicator
The RSI reading of 70.70 reflects elevated momentum conditions. Although short-term volatility may remain high, the indicator suggests the stock still retains substantial strength compared with its recent trading history.
Key Technical Levels
Based on the current price of INR 2,001.60, immediate support is placed near INR 1,901.52. A stronger support zone is located around INR 1,801.44, which is roughly 10% below current levels and could become important if selling pressure continues.
On the upside, the first resistance level is positioned near INR 2,101.68, approximately 5% above the current price. If the broader uptrend resumes, the next resistance zone could emerge around INR 2,201.76, representing nearly 10% upside from current levels.
Risks to Watch
- Sharp rallies often attract aggressive profit booking.
- Elevated RSI levels may lead to increased volatility.
- ASM monitoring could influence trading activity.
- Failure to hold support zones may weaken momentum.
Summary
Wockhardt shares witnessed a notable pullback after a powerful rally that pushed the stock above INR 2,100. While profit booking has emerged, the stock remains well above its 21-day SMA and continues to display a positive broader trend. Investors may watch whether the stock stabilizes near support levels as momentum remains elevated despite the recent correction.
FAQs
- Why did Wockhardt shares fall despite strong earnings?
The decline appears linked to profit booking after a steep rally rather than weakness in the company's financial performance.
- What is the key support level for WOCKPHARMA?
Immediate support is near INR 1,901.52, while stronger support is located around INR 1,801.44.
- What does the RSI indicate for the stock?
An RSI of 70.70 indicates elevated momentum, though the stock remains in overbought territory.